Treat breast inflammation with support for mental health
Treatments studied
Part of Mental health, Skin, Women’s health & pregnancy clinical trials.
This study looks at a non-surgical (“conservative”) approach to treating granulomatous lobular mastitis, along with help for mental health symptoms. It may help people whose breast inflammation and mental health concerns happen together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with granulomatous lobular mastitis (a specific type of breast inflammation)
- You also have a mental health condition or related symptoms
- You are willing to join and sign informed consent
- Your breast inflammation is not from a different confirmed cause found on pathology (tissue testing)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at surgical treatment for granulomatous lobular mastitis that has not been improving with non-surgical care. It may help people with more widespread or complicated breast inflammation, especially when there are abscesses or skin breakdown.
This study compares different surgical methods for treating granulomatous mastitis, a rare inflammatory breast condition. It aims to find which approach works best for patients who can safely have surgery.
This study compares two common treatments—antibiotics versus corticosteroid pills—to see which works better for granulomatous lobular mastitis (GLM), a type of breast inflammation. Participating may help find the best way to treat your condition.
This trial tests a medicine called tocilizumab for a painful breast condition called granulomatous lobular mastitis that has not improved with steroids. It may help reduce inflammation and avoid surgery.
This study compares two treatments for a rare breast inflammation called granulomatous mastitis. Half the participants will receive steroids, and the other half will receive methotrexate, to see which works better at reducing inflammation and symptoms.
This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.
Hear when a new Breast Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.